StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > More contagious BA.2 sub-variant spreading in Canada

<< Previous

Bullboard Posts

Next >>

Comment by Buynholdlongon Feb 22, 2022 11:59am

116 Views

Post# 34450491

RE:RE:RE:RE:More contagious BA.2 sub-variant spreading in Canada

Err on whichever side you want as long as you don't force others to do the same. Your judgment is your own. The danger is relative. Cowering must be optional so those with more fortitude can get on with their lives.

<< Previous

Bullboard Posts

Next >>

Nintendo stock jumps despite Q2 financials, new console news